Our Pricing

What to Do If You've Missed a Wegovy Dose

Published on: June 03, 2026

If you've experienced a missed Wegovy dose UK situation, you're not alone — life happens, and occasional missed injections are common among patients using semaglutide weight loss treatments. The good news is that in most cases, you can resume your treatment schedule safely with minimal disruption to your weight loss progress, though the specific action depends on how much time has passed since your scheduled dose.

Immediate Steps After Missing Your Wegovy Injection

The official MHRA-approved guidance for missed Wegovy doses follows a clear timeframe [1]. If fewer than 2 days (48 hours) have passed since your scheduled injection day, take your missed dose as soon as you remember. You can then continue with your regular weekly schedule as planned.

However, if more than 2 days have elapsed since your scheduled dose, skip the missed injection entirely and take your next dose on your regularly scheduled day [1]. Do not double up or take extra doses to 'catch up' — this increases the risk of gastrointestinal side effects such as nausea, vomiting, and diarrhoea without improving efficacy.

If you've missed more than two consecutive weekly doses, contact your prescriber before resuming treatment. Extended gaps in semaglutide therapy may require restarting at a lower dose to minimise side effects, as your body's tolerance to the medication can decrease during treatment interruptions [2].

Will Missing a Dose Affect Your Weight Loss Progress?

Missing a single Wegovy dose is unlikely to significantly derail your weight loss journey. In the STEP clinical trial programme, which demonstrated an average 14.9% body weight reduction over 68 weeks, occasional dosing interruptions were accounted for in real-world efficacy data [2].

Semaglutide, the active ingredient in Wegovy, has a half-life of approximately 7 days, meaning therapeutic levels remain in your system for several days after your last injection [1]. This extended pharmacokinetic profile provides some buffer if you miss an occasional dose, though consistent weekly dosing remains optimal for sustained appetite suppression and metabolic effects.

You may notice a temporary increase in appetite or slight weight fluctuation if you miss multiple doses, but this typically resolves once you resume your regular schedule. The key is returning to consistent dosing rather than attempting to compensate with dietary restriction or additional doses.

Long-Term Treatment Consistency

Clinical trials show that patients who maintain consistent dosing schedules achieve better long-term outcomes than those with frequent interruptions [2]. If you're regularly forgetting doses, consider setting phone reminders, choosing a specific day that aligns with your weekly routine, or using a medication tracking app to support adherence.

How to Prevent Missing Future Wegovy Doses

Establishing a reliable routine is the most effective strategy for consistent Wegovy adherence. Choose a specific day of the week that works with your schedule — many patients select Saturday or Sunday mornings when they have more time and are less rushed.

Store your Wegovy pens in a visible location in your refrigerator, ideally at eye level where you'll see them regularly. Some patients keep a calendar or chart on their fridge door to tick off each weekly injection, providing both a reminder and a visual record of adherence.

If you travel frequently, plan ahead by checking that your accommodation has refrigeration facilities. Wegovy pens can be kept at room temperature (up to 30°C) for up to 28 days if necessary, though refrigeration between 2-8°C remains the recommended storage method [1].

Digital Reminder Systems

Set up recurring weekly phone alerts for your injection day, ideally with a backup reminder 12 hours later in case you need to delay the dose within the same day. Many patients also benefit from adding their Wegovy schedule to shared family calendars so household members can provide gentle reminders.

When to Contact Your UK Prescriber About Missed Doses

If you've missed more than two consecutive weekly doses of Wegovy, contact your prescriber before resuming treatment. Extended treatment gaps may require a dose reduction or restart at an earlier maintenance level to minimise gastrointestinal side effects when reintroducing semaglutide [1].

You should also seek clinical guidance if you experience unusual symptoms after resuming treatment following a missed dose, particularly severe nausea, persistent vomiting, or signs of pancreatitis such as severe abdominal pain radiating to your back [3]. These symptoms, while uncommon, require prompt medical assessment.

At Cured Pharmacy, our UK-registered clinical team is available to review your treatment plan if you're experiencing adherence challenges. We can discuss strategies to improve consistency, assess whether your current dose remains appropriate, or consider alternative weight loss treatments if Wegovy's weekly injection schedule doesn't suit your lifestyle.

Comparing Wegovy to Alternative Weight Loss Treatments

If you're finding the weekly injection schedule difficult to maintain, alternative GLP-1 treatments may better suit your needs. Wegovy remains one of the most effective options available in the UK, with robust clinical trial data demonstrating significant weight loss outcomes [2].

Mounjaro (tirzepatide) offers a similar once-weekly injection schedule but works through a dual GIP/GLP-1 mechanism, achieving even greater average weight loss in head-to-head trials [4]. If injection frequency is the primary adherence barrier rather than the injection itself, Mounjaro won't solve that challenge, though some patients report preferring its side effect profile.

For patients who struggle with any injection-based treatment, Wegovy Oral Tablets provide a daily pill alternative containing semaglutide. While requiring daily adherence rather than weekly, some patients find oral medication easier to incorporate into existing routines. The clinical efficacy is comparable to injectable semaglutide when taken consistently [5].

Daily Injection Options

Saxenda (liraglutide) requires daily injections, which paradoxically helps some patients maintain better adherence through daily habit formation rather than remembering a weekly dose. However, the daily injection requirement doesn't suit everyone, and average weight loss is typically lower than with weekly semaglutide or tirzepatide treatments [6].

Restarting Wegovy After an Extended Break

If you've been off Wegovy for more than two weeks, your prescriber will likely recommend restarting at a lower dose than your previous maintenance level. This dose escalation approach mirrors the initial titration schedule and helps your body readjust to semaglutide's effects while minimising gastrointestinal side effects [1].

The standard Wegovy dose escalation begins at 0.25mg weekly for four weeks, increasing gradually to 0.5mg, 1mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly [1]. Your prescriber may accelerate this schedule slightly if you were previously tolerating higher doses well, but patient safety requires a cautious reintroduction approach.

Don't be discouraged if restarting feels like going backwards — your body retains metabolic adaptations from your previous treatment period, and many patients find they progress through dose escalation more quickly the second time. The priority is establishing consistent adherence moving forward rather than rushing back to your previous dose level.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 receptor agonists: Reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued. Drug Safety Update, 16(9). https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
4. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. Knop, F. K., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402(10403), 705–719. https://doi.org/10.1016/S0140-6736(23)01185-6 [accessed 13 August 2026]
6. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or if you have concerns about missed doses.